Zoetis Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Zoetis Inc. (ZTS) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $6.00 million for the 6-month period ending 2015-06-28, per its 10-Q filed 2015-08-06.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2017-02-16
- Zoetis Inc. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2015-06-28 was -$3.00M, a 400.00% decline year-over-year.
- Zoetis Inc. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2015-03-29 was $9.00M, a 12.50% increase year-over-year.
- Zoetis Inc. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2014-12-31 was $0.00.
- Zoetis Inc. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2014-09-28 was -$1.00M.
- Zoetis Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2014 was $8.00M.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 3 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 6 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 6 month as first filed | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 9 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|---|---|---|---|
| 2015-06-28 | -$3.00M derived: 10-Q 6 month − 10-K 3 month · filed 2015-08-06 | $6.00M 10-Q · filed 2015-08-06 | $6.00M derived: sum of 3 quarters · filed 2016-02-24 | $5.00M derived: sum of 4 quarters · filed 2016-02-24 | |
| 2015-03-29 | $9.00M 10-K · filed 2016-02-24 | $9.00M derived: sum of 2 quarters · filed 2016-02-24 | $8.00M derived: sum of 3 quarters · filed 2016-02-24 | $9.00M derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$1.00M derived: sum of 2 quarters · filed 2016-02-24 | $0.00 derived: sum of 3 quarters · filed 2016-02-24 | $8.00M 10-K · filed 2016-02-24 | |
| 2014-09-28 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2015-08-06 | $8.00M 10-Q · filed 2014-11-10 | ||
| 2014-06-29 | $1.00M derived: 10-Q 6 month − 10-K 3 month · filed 2015-08-06 | $9.00M 10-Q · filed 2015-08-06 | $8.00M 10-Q · filed 2014-08-12 | ||
| 2014-03-30 | $8.00M 10-K · filed 2017-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |